CCS
HOLX

Crosspoint Capital Strategies’s Hologic HOLX Stock Holding History

Crosspoint Capital Strategies’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-82
Closed -$3K – 1079
2015
Q3 		$3K Sell
82
-181,634
-100% -$7.2M ﹤0.01% 565
2015
Q2 		$6.92M Buy
+181,716
New +$6.36M 1.96% 13

Other funds holding HOLX

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TCM
Tran Capital Management San Rafael, California $869M AUM 52.91% 1-Year Est. Return

Crosspoint Capital Strategies's HOLX Position: Q4 2015 in Review

Crosspoint Capital Strategies sold out of Hologic (HOLX) in Q4 2015, closing a stake of 82 shares — an estimated $3K sold.

Crosspoint Capital Strategies first reported a position in HOLX in Q2 2015 and held it in 2 quarters. The position peaked at $6.92M in Q2 2015. 451 funds tracked by Wall St. Rank hold HOLX as of Q4 2015.

  • Crosspoint Capital Strategies reported no remaining Hologic position as of Q4 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 82 Hologic shares in Q4 2015, an estimated $3K.
  • Crosspoint Capital Strategies first reported a position in Hologic in Q2 2015 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Hologic position peaked at $6.92M in Q2 2015.
  • 451 funds tracked by Wall St. Rank held Hologic as of Q4 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.